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ABSTRACT 
BACKGROUND: Breast carcinoma is the most common cancer among women, also 
tops the list of cancer death among women, living in under developed countries. The 
mortality of breast carcinoma is attributed to metastatic disease.CD10 is a 90-110 kD 
cell surface metalloproteinase, that may play a role in degrading extra cellular matrix 
and collagen, providing a microenvironment favourable for invasion and metastasis. 
AIM AND OBJECTIVES: 
 To study the stromal expression of CD 10 antigen in patients diagnosed 
as invasive ductal breast carcinoma by histopathological examination. 
 To  study  relationship  with:  
 1.  Age, 2.  Menopausal status 3. Histologic subtypes 4.Nottingham’s 
grade and 3. Nottingham’s Prognostic index, 4. Mitotic rate and 
5.Lymph node metastasis of the patients. 
MATERIALS AND METHODS: 
A total of 60 patients of breast cancer were included in the study. Representative 
sections were taken and Hematoxylin and Eosin staining was done. 
Immunohistochemistry was performed with CD10. Stromal expression of CD10 
(10%-30% stromal positivity was considered weak positive, >30% as strong positive) 
in invasive breast carcinoma was noted and was statistically analysed. 
RESULTS: 
Stromal expression of CD10 was found to be significantly associated with increasing 
tumor grade (P = 0.047), Lymph node metastasis (P = 0.013) and Nottingham’s 
Prognostic index (P = 0.009). No correlation was found between CD10 expression 
and age, menopausal status, histologic subtypes, tumour size and mitotic rate. 
 
CONCLUSION 
  The  stromal  expression  of  CD10  has  significant  correlation  
with  higher  histological  grade  ,  lymph node metastasis, Nottingham’s 
prognostic index. There is no correlation between CD10 expression and age 
menopausal status, histologic subtypes, tumour size and mitotic rate. 
 This  study  highlights  the  role  of  stromal  CD10  expression  in  
predicting  tumor  response  and  prognosis. Hence CD10 could be used as a 
prognostic marker. 
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